Sign in

LIGHTS

@lightsdatabase.bsky.social
287 followers 146 following 12 posts

Library of Guidance for Health Scientists (www.lights.science). A searchable database of otherwise difficult-to-find methods guidance. Posts by @sschandelmaier.bsky.social

PostsRepliesMedia
LIGHTS @lightsdatabase.bsky.social · 10/11/2025
Dear @bmj.com, Can you please fix the lack of abstracts in MEDLINE meta-data for your articles in "Methods and Reporting"? We include many of them in the open-access @lightsdatabase.bsky.social but searchability isn't great without abstracts. Extracting abstracts from PDFs is not feasible. Thanks!
000
Reposted by LIGHTS
Triad sou. @triadsou.bsky.social · 02/10/2025
Handling Missingness, Failures, and Non-Convergence in Simulation Studies: A Review of Current Practices and Recommendations. Samuel Pawel, František Bartoš, Björn S. Siepe, Anna Lohmann. The American Statistician. www.tandfonline.com/doi/full/10....
tandfonline.com
Handling Missingness, Failures, and Non-Convergence in Simulation Studies: A Review of Current Practices and Recommendations
Simulation studies are commonly used in methodological research for the empirical evaluation of data analysis methods. They generate artificial datasets under specified mechanisms and compare the p...
001
LIGHTS @lightsdatabase.bsky.social · 18/05/2025
bmcmedresmethodol.biomedcentral.com/articles/10....
bmcmedresmethodol.biomedcentral.com
Equality, equity, diversity, and inclusion principles: how should we apply these to statistical methodology research? - BMC Medical Research Methodology
Background The aim of equality, equity, diversity, and inclusion (EDI) is to ensure fair treatment, equal opportunities, equitable outcomes, and representation. The NIHR Research Design Service (RDS) ...
000
Reposted by LIGHTS
Gary Collins @gscollins.bsky.social · 29/04/2025
NEW PAPER: Updated SPIRIT-2025 for reporting protocols of randomised trials is now available in the @BMJ.com, @JAMA.com, @thelancet.bsky.social, @PLoS.org, and @natmedicine.bsky.social. —> www.bmj.com/content/389/... #openscience #transparency #medsky #statssky #episky
12622
LIGHTS @lightsdatabase.bsky.social · 16/04/2025
www.bmj.com/content/389/...
bmj.com
CONSORT 2025 statement: updated guideline for reporting randomised trials
Background Well designed and properly executed randomised trials are considered the most reliable evidence on the benefits of healthcare interventions. However, there is overwhelming evidence that the...
010
LIGHTS @lightsdatabase.bsky.social · 29/03/2025
Open-access book. Thanks, Anthony Jorm! link.springer.com/book/10.1007...
link.springer.com
Expert Consensus in Science
This open access book explores how expert consensus shapes science, guiding truth, policy, and practice, while proposing improvements.
010
Reposted by LIGHTS
Tim Feeney @tfeend.bsky.social · 26/03/2025
New paper in @bmj.com. Ever been told ‘what does your DAG say?” or “show me your DAG”, or “ok draw a DAG” and not sure what that means or how to get started? Well buckle up, because Fernando Hartwig, @neilmdavies.bsky.social and I wrote an RMR on just this topic. www.bmj.com/content/388/...
media.tenor.com
Dags Yda Like Dags Mickey Oniel GIF
ALT: Dags Yda Like Dags Mickey Oniel GIF
65626
Reposted by LIGHTS
JBI @jbiebhc.bsky.social · 27/03/2025
🎉We are excited to announce the release of updated methodology for qualitative evidence synthesis! Updates include several new sections, such as equity qualitative evidence synthesis and reflexivity. 🔖 Bookmark the updated methodology: jbi-global-wiki.refined.site/space/MANUAL... #JBImethodology
031
Reposted by LIGHTS
Gary Collins @gscollins.bsky.social · 24/03/2025
NEW PAPER in the @bmj.com "PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or #artificialintelligence methods" www.bmj.com/content/388/... #StatsSky #MLSky #AI #MethodologyMatters
12811
Reposted by LIGHTS
The BMJ @bmj.com · 25/03/2025
Risk of bias assessment of randomised controlled trials has become an essential step in the systematic review process. A new tool allows users to assess risk of bias of RCTs included in systematic reviews in a user friendly way www.bmj.com/content/388/...
Bias written in wooden blocks
0269
Reposted by LIGHTS
Julia M. Rohrer @dingdingpeng.the100.ci · 20/03/2025
New blog post! In which I explain the issue with mediation analysis and sketch out one way to deal with the underlying causal inference problem -- in just a bit over 1,000 words! If you have never found the time to read up on this, now is your chance. www.the100.ci/2025/03/20/r...
the100.ci
Reviewer notes: That’s a very nice mediation analysis you have there. It would be a shame if something happened to it.
Mediation analysis has gotten a lot of flak, including classic titles such as “Yes, but what’s the mechanism? (Don’t expect an easy answer)” (Bullock et al., 2010), “What mediation analysis can (not) ...
26452138
LIGHTS @lightsdatabase.bsky.social · 13/03/2025
Just published the Taxonomy & Thesaurus for Health Research Methodology (THEREMY), the emerging vocabulary underlying LIGHTS. It's still patchy but will grow and improve in tandem with LIGHTS. Each term includes a link to LIGHTS. Suggestions are welcome! loterre.istex.fr/Theremy/en/ #LOTERRE
loterre.istex.fr
: Taxonomy & Thesaurus for Health Research Methodology
110
Reposted by LIGHTS
Marion Campbell @marionkcampbell.bsky.social · 10/03/2025
A common issue in trials is how to accommodate multiple important outcomes. Approaches include composite outcomes or using the win ratio method (I have posted on these before). A newer method is the #DOOR (Desirability of Outcome Ranking) approach 1/7  #MethodologyMonday #113
3247
Reposted by LIGHTS
Miguel Hernan @miguelhernan.org · 18/02/2025
1/ When using observational data for #causalinference, emulating a target trial helps solve some problems... but not all problems. In a new paper, we explain why and when the #TargetTrial framework is helpful. www.acpjournals.org/doi/10.7326/... Joint work with my colleagues @causalab.bsky.social
34612
Reposted by LIGHTS
Carl T. Bergstrom @carlbergstrom.com · 15/02/2025
This excellent interactive tutorial on misleading data visualizations explores the idea of a "counter chart" — the graph you draw in response to refute a misleading claims flowingdata.com/projects/dis...
flowingdata.com
Defense Against Dishonest Charts
This is a guide to protect ourselves and to preserve what is good about turning data into visual things.
531211441
Reposted by LIGHTS
TRIPOD Statement @tripodstatement.bsky.social · 13/02/2025
TRIPOD+AI (Expanded E&E): "If uncertainty intervals for individual prediction model outputs have been presented then provide details on how this was done" (www.bmj.com/content/385/...) 👇This new paper provides insight into uncertainty of risk estimate on decision making www.bmj.com/content/388/...
088
Reposted by LIGHTS
UCL Innovative Clinical Trials Unit @innovative-ctu.bsky.social · 10/02/2025
This new paper explores the best way to implement reference-based multiple imputation for longitudinal binary data in #ClinicalTrials where data are missing after participants deviate from their assigned treatment. Read now👇 buff.ly/4jJtGOW @matteoq21.bsky.social @suziecro.bsky.social
buff.ly
Reference-Based Multiple Imputation for Longitudinal Binary Data
Reference-based multiple imputation provides a practical information anchored tool for inferences about the treatment effect for a treatment policy estimand with a longitudinal binary outcome. The latent multivariate normal model is the preferred implementation.
073
LIGHTS @lightsdatabase.bsky.social · 08/02/2025
pubmed.ncbi.nlm.nih.gov/39108176/
pubmed.ncbi.nlm.nih.gov
Introduction to network meta-analysis: understanding what it is, how it is done, and how it can be used for decision-making - PubMed
Network meta-analysis (NMA), a statistical technique that allows systematic reviewers to simultaneously compare more than two alternatives, makes use of indirect evidence from studies comparing interv...
000
Reposted by LIGHTS
Brennan Kahan @brennankahan.bsky.social · 04/02/2025
Working on a factorial trial? The Explanation and Elaboration paper for the CONSORT and SPIRIT factorial extensions is now out in @bmj.com It includes: -examples of how to report factorial trials -a methodology summary around the design/conduct/analysis of these trials www.bmj.com/content/388/...
bmj.com
Guidance for protocol content and reporting of factorial randomised trials: explanation and elaboration of the CONSORT 2010 and SPIRIT 2013 extensions
This report presents the explanation and elaboration paper for the CONSORT (Consolidated Standards of Reporting Trials) 2010 and SPIRIT (Standard Protocol Items: Recommendations for Interventional Tri...
01711
LIGHTS @lightsdatabase.bsky.social · 03/02/2025
www.sciencedirect.com/science/arti...
sciencedirect.com
Random effects structure for confirmatory hypothesis testing: Keep it maximal
Linear mixed-effects models (LMEMs) have become increasingly prominent in psycholinguistics and related areas. However, many researchers do not seem t…
000
Reposted by LIGHTS
Mark Rubin @markrubin.bsky.social · 29/01/2025
Three Myths About Statistical Power 🔹️ Myth 1: Power is an objective feature 🔹️ Myth 2: With low power comes low credibility 🔹️ Myth 3: High power protects against questionable research practices BSky author: @clauslamm.bsky.social
psychologicalscience.org
Powerful Myths: Common Misconceptions About Statistical Power
Lukas Lengersdorff and Claus Lamm discuss three misconceptions that stand in the way of an informed discussion.
58121
Reposted by LIGHTS
Rushani Wijesuriya @rush-099.bsky.social · 27/01/2025
Hot off the press! 📣📣In this tutorial we illustrate available multiple imputation approaches for handling longitudinal data including when they are clustered within higher level clusters. A reproducible example with R and Stata code provided! #OpenAccess onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
Multiple Imputation for Longitudinal Data: A Tutorial
Longitudinal studies are frequently used in medical research and involve collecting repeated measures on individuals over time. Observations from the same individual are invariably correlated and thu....
515064
Reposted by LIGHTS
Marion Campbell @marionkcampbell.bsky.social · 27/01/2025
An issue that often comes up is how to set a “non-inferiority margin” in a non-inferiority trial and how to ensure it is appropriate 1/8 #MethodologyMonday #109
23522
Reposted by LIGHTS
Darren Dahly @statsepi.bsky.social · 24/01/2025
... @nicolewhite.bsky.social and @aidybarnett.bsky.social have already got this out there. Very nice! Read it. Cite it. Spread the message friends. www.bmj.com/content/388/...
bmj.com
Appropriate statistical methods are necessary for ethical medical research
As medical statisticians, we welcome revisions to the Declaration of Helsinki emphasising the importance of appropriate methods to reduce research waste.1 The declaration now states that rigorous stu...
0196
Reposted by LIGHTS
Andrew Gelman et al. @statmodeling.bsky.social · 23/01/2025
When estimating a treatment effect with a cluster design, you need to include varying slopes, even if the fit gives warning messages. statmodeling.stat.columbia.edu/2025/01/23/s...
statmodeling.stat.columbia.edu
When estimating a treatment effect with a cluster design, you need to include varying slopes, even if the fit gives warning messages. | Statistical Modeling, Causal Inference, and Social Science
35315
Reposted by LIGHTS
Daniel Lakens @lakens.bsky.social · 17/01/2025
If you would like to read what I hope (and tried) to make the best (=most conceptually rigorous) review of preregistration and Registered Reports currently in the literature, see our recent paper: www.tandfonline.com/doi/full/10....
tandfonline.com
The benefits of preregistration and Registered Reports
Practices that introduce systematic bias are common in most scientific disciplines, including toxicology. Selective reporting of results and publication bias are two of the most prevalent sources o...
1135
Reposted by LIGHTS
JAMA @jama.com · 15/01/2025
JAMA Guide to Statistics and Methods: Factorial clinical trial designs allow for the simultaneous evaluation of multiple treatments and their interactions. ja.ma/4gTWOB8 #MedSky
Figure. Treatment Groups in an Example 2 x 2 Factorial Clinical Trial
03114
LIGHTS @lightsdatabase.bsky.social · 11/01/2025
pubmed.ncbi.nlm.nih.gov/39038802/
pubmed.ncbi.nlm.nih.gov
Systematic reviews of the literature: an introduction to current methods - PubMed
Systematic reviews are a type of evidence synthesis in which authors develop explicit eligibility criteria, collect all the available studies that meet these criteria, and summarize results using repr...
000
Reposted by LIGHTS
Andrew Vickers @vickersbiostats.bsky.social · 09/01/2025
"If you are going to write a scientific paper for publication, you are also going to have to write a response to reviewers". Advice on "How to write a response to reviewers" from a group of editors who've ready many, many thousands of such responses. www.europeanurology.com/article/S030...
01710
Reposted by LIGHTS
Stephen Burgess @stevesphd.bsky.social · 08/01/2025
Our work on immortal time bias "Illustrating the structures of bias from immortal time using directed acyclic graphs" led by Emma Guoyi Yang @yanggy_hku is out at International Journal of Epidemiology: doi.org/10.1093/ije/.... Brief thread:
doi.org
Illustrating the structures of bias from immortal time using directed acyclic graphs
AbstractBackground. Immortal time is a period of follow-up during which death or the study outcome cannot occur by design. Bias from immortal time has been
45625
Reposted by LIGHTS
Brennan Kahan @brennankahan.bsky.social · 07/01/2025
New CONSORT extension for cluster-crossover trials published in @bmj.com www.bmj.com/content/388/...
bmj.com
Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration
This article presents the CONSORT (consolidated standards of reporting trials) extension for cluster randomised crossover trials. A cluster randomised crossover trial involves randomisation of groups ...
02216
Reposted by LIGHTS
Miguel Hernan @miguelhernan.org · 23/12/2024
Upgrade your #causalinference arsenal. A revision of our book "Causal Inference: What If" is available at miguelhernan.org/whatifbook Thanks to everyone who suggested improvements, reported typos, and proposed new citations and material. Enjoy the #WhatIfBook plus code and data. Also, it's free.
10373113
Reposted by LIGHTS
Maarten van Smeden @maartenvsmeden.bsky.social · 23/12/2024
Let us start 2025 in a positive mood: here are 10 methods things researchers can worry *less* about in 2025
media.tenor.com
a countdown clock with the number 10 in the center
ALT: a countdown clock with the number 10 in the center
15259119
Reposted by LIGHTS
Maarten van Smeden @maartenvsmeden.bsky.social · 16/12/2024
NEW PREPRINT A detailed overview of 32 popular predictive performance metrics for prediction models arxiv.org/abs/2412.10288
1119565
LIGHTS @lightsdatabase.bsky.social · 10/12/2024
Adjusting for covariates in trials www.fda.gov/regulatory-i...
fda.gov
Guidance for Industry
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
000
Reposted by LIGHTS
Journal of Clinical Epidemiology @jclinepi.bsky.social · 01/12/2024
Using causal diagrams within the Grading of Recommendations, Assessment, Development and Evaluation framework to evaluate confounding adjustment in observational studies - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
jclinepi.com
Using causal diagrams within the Grading of Recommendations, Assessment, Development and Evaluation framework to evaluate confounding adjustment in observational studies
The current Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system instructs appraisers to evaluate whether individual observational studies have sufficiently adjusted for c...
1186
Reposted by LIGHTS
Journal of Clinical Epidemiology @jclinepi.bsky.social · 28/11/2024
Methodological Quality Assessment Tools for Diagnosis and Prognosis Research: Overview and Guidance - @jclinepi.bsky.social www.jclinepi.com/article/S089...
jclinepi.com
Methodological Quality Assessment Tools for Diagnosis and Prognosis Research: Overview and Guidance
Multiple tools exist for assessing the methodological quality of diagnosis and prognosis research. It can be challenging to decide on when to use which tool. We aimed to provide an overview of existin...
1125
Reposted by LIGHTS
Marion Campbell @marionkcampbell.bsky.social · 25/11/2024
Many of you know I post something about methods most Mondays on the “other side”… will share here too. Here is today’s … It is often important to assess not only the effectiveness of an interventions in a trial but also the #CostEffectiveness of the intervention 1/7 #MethodologyMonday #106
1339
Reposted by LIGHTS
Marion Campbell @marionkcampbell.bsky.social · 25/11/2024
Petrou and Gray published a really helpful primer paper on how to design and conduct an economic evaluation alongside a trial 3/7 www.bmj.com/content/342/...
121
Reposted by LIGHTS
Munya Dimairo @mdimairo.bsky.social · 25/11/2024
A good regulatory lay summary of the rationale for borrowing information in patient subgroups and shrinkage estimation in Bayesian hierarchical models www.fda.gov/drugs/regula...
fda.gov
Using innovative statistical approaches
Using Bayesian hierarchical models, CDER statisticians are improving our understanding of how drugs affect different groups of patients
001
Reposted by LIGHTS
TRIPOD Statement @tripodstatement.bsky.social · 23/11/2024
With the large and growing number of prediction models, systematic reviews to evaluate and summarise the overall evidence available are important, so we developed TRIPOD-SRMA to provide guidance on reporting these studies tinyurl.com/33ffsj9k #evidencesynthesis #systematicreviews
193
Reposted by LIGHTS
James Bartlett @bartlettje.bsky.social · 22/11/2024
I've added a little code peer-review activity for the final week of my introductory research methods course. I came across this great concise article which outlines what elements to include for code-review in the sciences: onlinelibrary.wiley.com/doi/full/10....
onlinelibrary.wiley.com
Implementing code review in the scientific workflow: Insights from ecology and evolutionary biology
Code review is the process of either informally (as part of a group, as colleagues) or formally (as part of the peer review process) checking and evaluating each other's code and is a critical method...
12911
LIGHTS @lightsdatabase.bsky.social · 20/11/2024
Helpful take on how tests work in general allendowney.blogspot.com/2016/06/ther...
000
Reposted by LIGHTS
Andrew Vickers @vickersbiostats.bsky.social · 14/11/2024
My first post on BlueSky has to be about decision curve analysis, right? We created a website to make it very easy for everyone. Code, tutorials, references can all be found at www.decisioncurveanalysis.org
decisioncurveanalysis.org
DCA: Homepage
If you can’t find an answer to a question in one of the other tabs, click on the “Discussions” tab, which will navigate you to the GitHub discussions forum for all Q&A. If you post a question, someone from our team will get back to you.
2368
Reposted by LIGHTS
Daniel Westreich @epidbydesign.bsky.social · 28/07/2023
If you teach epidemiology and might be interested in using my textbook (EPIDEMIOLOGY BY DESIGN) -- I will send you ALL MY TEACHING MATERIALS (lecture slides; practice problems; exercises; exams + keys; sample syllabi...). Just ask! And also www.epidemiologybydesign.com
epidemiologybydesign.com
Epidemiology By Design
54819
Reposted by LIGHTS
Maarten van Smeden @maartenvsmeden.bsky.social · 11/11/2024
Which reminds me of this Andrew Vickers quote www.nature.com/articles/ncp...
56822
Reposted by LIGHTS
Miguel Hernan @miguelhernan.org · 18/05/2024
With #TargetTrial emulation becoming increasingly popular, it's important to understand what it can and can't do. In this podcast I discuss how target trial emulation can improve causal inference from observational data and extend inferences from randomized trials edhub.ama-assn.org/jn-learning/...
edhub.ama-assn.org
Target Trial Emulation for Causal Inference From Observational Data With Dr Hernán
Miguel A. Hernán, MD, DrPH, professor of epidemiology, Harvard T.H. Chan School of Public Health, discusses Target Trial Emulation: A Framework for Causal Inference From Observational Data with JAMA Statistical Editor Roger J. Lewis, MD, PhD.
0119